---
schema_version: "secwatch.filing_event.v1"
accession: "0001801170-24-000158"
form_type: "8-K"
ticker: "CLOV"
cik: "0001801170"
company_name: "CLOVER HEALTH INVESTMENTS, CORP. /DE"
filed_at: "2024-08-05T23:59:59+00:00"
generated_at: "2026-05-31T13:12:07.648625+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Clover Health Q2 2024: first GAAP net income of $7.2M, raises FY2024 guidance

## Summary
- Q2 GAAP net income from continuing operations $7.2M vs. loss of $28.9M in Q2 2023; first positive quarter.
- Total revenue $356.3M, up 11% YoY; Insurance revenue $349.9M, also up 11%.
- Insurance MCR improved to 71.3% from 77.2% (590 bps improvement); Insurance BER improved to 76.1%.
- Adjusted EBITDA $36.2M vs. $9.9M in Q2 2023.
- FY2024 guidance raised: Insurance revenue $1.35B-$1.375B, Adjusted EBITDA $50M-$65M (from $10M-$30M).

## SEC filing metadata
- accession: 0001801170-24-000158
- form_type: 8-K
- ticker: CLOV
- cik: 0001801170
- company_name: CLOVER HEALTH INVESTMENTS, CORP. /DE
- filed_at: 2024-08-05T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1801170/000180117024000158/0001801170-24-000158-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1801170/000180117024000158/clov-20240805.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001801170-24-000158
- JSON: https://secwatch.observer/filing/0001801170-24-000158.json
- Plain text: https://secwatch.observer/filing/0001801170-24-000158.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.